3Lai CL,Chien RN,Leung NWY，et al.A one -year trial of lamivudine for chronic hepatitis B[J]．N Engl J Med，1998，339：61.
4Sokal E，Roberta EA，Mieli-Vergani G,et al.Dose—finding and safety of Iamivudine in children and adolescents with ehronie hepatitis B(abstract)[J].Hepatology,1998,28(4pt2)489A.
5Lai CI,Ching CK,Tung AKM，et a1．Lamivudine is effective in suppreasing bepatitis B virus DNA in chinese hepatitis B surface antigen carriers:a placebo-controlled trial[J]．Hepatology，1997，25：241.
6Allen MI，Dealauriers M，Andrews W，et a1．Identification and characterization of mutations in hepatitis B virus resistant to almivudine[J].Hepatology ,1998，27：1670．
7Chayama K，Yoshiyuki S，Kobayashi M，et al,Emergence and takeover of YMDD matif matant hepatitis B virus duing long-term lamivudine therapy and re-takeover by wild type after cessation of therapy[J].Hepatology,1998.27：1711.
8Niesters HGM,Honkoop P，Haagama EB，et a1．Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment [J]．J Infect Dis，1998，177：1382．
9Tipplea GA，Ma MM,Fischer KP,et al．Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivadine in vivo[J].Hepatology,1996.24:714.
10Melegari M, Scaglioni PP, Wands JR,et al.Hepstitis B virus mutations associated with 3TC and Famciclovir administration are replication delective[J]. Hepatology, 1998,27:628.
